Posted by Michael Wonder on 22 Dec 2024
Dong-A ST secures European approval for Stelara biosimilar Imuldosa
19 December 2024 - Global market expansion accelerates with back to back FDA and EC authorisations.
Dong-A ST proudly announces that its Stelara biosimilar, Imuldosa (ustekinumab), has received marketing authorisation from the European Commission as of December 18.
